by Sue Robbins | May 5, 2016 | Headache Drugs
Headache worsening after treatment with IV dihydroergotamine (DHE) does not predict poor headache outcome in the medium term among patients with chronic migraine, according to research published March 1 in Neurology. According to researchers, headache exacerbation is...
by Sue Robbins | Apr 22, 2016 | Headache Drugs
Botox is a safe and effective treatment for chronic migraine. Botulinum toxin is made by a type of bacteria long used to smooth wrinkles. The toxin blocks the release of substances at nerve endings, reducing muscle contraction and the transmission of pain signals. The...
by Sue Robbins | Apr 20, 2016 | Headache Drugs
The following list of factors are used when deciding what headache medications to use…. Frequency and severity of headache Previous response to various medications Sensitivity and side effects from the medications Psychiatric comorbidities and insomnia medical...
by Sue Robbins | Mar 28, 2016 | Headache Drugs
Wsj.com reporter Jonathan D. Rockoff reports on new medicines, now in late stages of development for migraine pain… Researchers are unlocking some of the mysteries surrounding migraines, raising hopes for a new class of treatments. Millions of patients who...
by Sue Robbins | Sep 29, 2015 | Headache Drugs
A Canadian research team led my Dr. Mark Ware from the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal has completed a national multicentre study looking at the safety of medical cannabis use among patients suffering from chronic pain....
by Sue Robbins | Aug 14, 2015 | Headache Drugs
Distinguishing between regular depression and bipolar depression can be a tough call for physicians. The symptoms are similar, but medications that ease depression can make bipolar patients worse by triggering mania episodes. The dilemma is fueling new research...
